On May 16th, The Council on Strategic Risks (CSR) hosted an event on the federal government’s strategy for driving innovation in biomanufacturing. The panel event featured expert perspectives from Dr. Georgia Lagoudas, Mr. Maynard Holliday, and Dr. Anup Singh. The panelists discussed how the federal interagency is positioning itself to capitalize on the transformative effects of biotechnology through investments in biomanufacturing.
Nolan Center experts examine the Biden Administration's new National Biodefense Strategy and Implementation Plan and its accompanying National Security Memorandum.
By Jackson duPont This summer was my first time diving into the world of biosecurity. As an intern for the Council of Strategic Risks, I expected to learn about new areas of security, and this experience was particularly salient given…
Read More The Future of Biodefense: Turning the Curse of Knowing into a Blessing
By Andrea Rezzonico New Zealand's latest biodefense assessment published by its Ministry of Defence incorporates a "converging risks" approach by spotlighting the intersection of biological and climate threats and their attendant security implications. Persistent and intensifying disruptors highlighted in the…
Read More New Zealand’s Biodefence Assessment Incorporates Converging Risks Approach
